Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04202393 · ClinicalTrials.gov registry record · NA

Intervention for Comorbid Substance Use and Bipolar Disorders

A NA study, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
178
Enrollment target

NCT04202393 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 178 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04202393, a NA study, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target

Study Summary

This trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive an enhanced safety monitoring program, both provided in addition to their routine care.

Interventions

  • BEHAVIORAL Integrated Treatment Adherence Program (ITAP)
  • BEHAVIORAL Safety Assessment and Follow-up Evaluation (SAFE)

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2020-10-21
Est. Completion 2025-08-31
Phase NA

Sponsor

Butler Hospital

103 total trials

What the Registry Record Tells You About NCT04202393

The ClinicalTrials.gov registry entry for NCT04202393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Integrated Treatment Adherence Program (ITAP) is the first listed.

NCT04202393 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04202393 about?

NCT04202393 is a clinical study titled "Intervention for Comorbid Substance Use and Bipolar Disorders". This trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive a...

What is the current status of trial NCT04202393?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2020-10-21. Estimated completion is 2025-08-31.

What interventions are being tested in trial NCT04202393?

The interventions under investigation include: Integrated Treatment Adherence Program (ITAP) (BEHAVIORAL), Safety Assessment and Follow-up Evaluation (SAFE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04202393?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.